Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRegion Stockholm
About this trial
An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.
Eligibility criteria
Qualifiers
Adults 18 years or older
Critical care after subarachnoid haemorrhage
Aneurysm secured by surgical clipping or endovascular procedure
Suspected, emerging or established severe cerebral vasospasm
Disqualifiers
Anticipated survival less than five days, as determined by treating clinician
Transcranial Doppler signal too weak
Pregnancy
Trial design
Treatments tested in this trial
- Induced hypertension with norepinephrine
- Endoluminal Spasmolysis
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Region Stockholm
Lead sponsor
Karolinska Institutet
Sponsor institution
Karolinska Institutet
Collaborator
Source ClinicalTrials.gov